Synthesis and Biological Activity of Novel Platencin Derivatives

Dennis C. J.Waalboer, Floris P. J.T. Rutjes

Abstract


The biological mode of action of platencin, a potential lead molecule for a new class of antibiotics, is detailed. Furthermore, enantiopure syntheses of several platencin derivatives are described, of which the core structure can be accessed in two exceedingly simple steps from commercially available starting materials. Furthermore, the antibiotic properties of the derivatives was evaluated.

Full Text:

PDF

References


Lock, R.L. & Harry, E.J., Cell-Division Inhibitors: New Insights for Future Antibiotics, Nat. Rev. Drug Discov., 7, 324-338, 2008.

Hughes, B., 2009 FDA Drug Approvals, Nat. Rev. Drug Discov., 9, 89-92, 2010.

a) Leadbetter, M.R., Adams, S. M., Bazzini, B., Fatheree, P.R., Karr, D.E., Krause, K.M., Lam, B.M.T., Linsell, M.S., Nodwell, M.B., Pace, J.L., Quast, K., Shaw, J.P., Soriano, E., Trapp, S.G., Villena, J.D., Wu, T.X., Christensen, B.G. & Judice, J.K., Hydrophobic Vancomycin Derivatives with Improved ADME Properties: Discovery of Telavancin (TD-6424), J. Antibiot., 57, 326-336, 2004. b) Corey, G.R., Stryjewski, M.E., Weyenberg, W., Yasothan, U. & Kirkpatrick, P., Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating The Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections, Nat. Rev. Drug Discov., 8, 929-930, 2009.

Spellberg, B., Powers, J.H., Brass, E.P., Miller, L.G. & Edwards, J.E., Trends in Antimicrobial Drug Developments: Implications for The Future, Clin. Infect. Dis., 38, 1279-1286, 2004.

DiMasi, J.A., Hansen, R.W. & Grabowski, H.G., The Price of Innovation: New Estimates of Drug Development Costs, J. Health Econ., 22, 151-185, 2003.

Hughes, B., 2008 FDA Drug Approvals, Nat. Rev. Drug Discov., 8, 10-11, 2009.

Wang, J., Soisson, S.M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y.S., Cummings, R., Ha, S., Dorso, K., Motyl, M., Jayasuriya, H., Ondeyka, J., Herath, K., Zhang, C., Hernandez, L., Allocco, J., Basilio, Á., Tormo, J.R., Genilloud, O., Vicente, F., Pelaez, F., Colwell, L., Lee, S.H., Michael, B., Felcetto, T., Gill, C., Silver, L.L., Hermes, J.D., Bartizal, K., Barrett, J., Schmatz, D., Becker, J.W., Cully,D. & Singh, S.B., Platensimycin is a Selective FabF Inhibitor with Potent Antibiotic Properties, Nature, 441, 358-361, 2006.

a) Jayasuriya, H., Herath, K.B., Zhang, C., Zink, D.L., Basilio, A., Genilloud, O., Diez, M.T., Vicente, F., Gonzalez, I., Salazar, O., Pelaez, F., Cummings, R., Ha, S., Wang, J. & Singh, S.B., Isolation and Structure of Platencin: a FabH and FabF Dual Inhibitor with Potent Broad-Spectrum Antibiotic Activity, Angew. Chem. Int. Ed., 46, 4684-4688, 2007. b) Wang, J., Kodali, S., Lee,S.H., Galgoci, A., Painter, R., Dorso, K., Racine, F., Motyl, M., Hernandez, L., Tinney, E., Colletti, S.L., Herath, K., Cummings, R., Salazar, O., González, I., Basilio, A., Vicente, F., Genilloud, O., Pelaez, F., Jayasuriya, H., Young, K., Cully, D.F. & Singh, S.B., Discovery of Platencin, a dual FabF and FabH Inhibitor with In Vivo Antibiotic Properties, Proc. Natl. Acad. Sci. USA, 104, 7612-7616, 2007.

White, S.W., Zheng, J., Zhang, Y.M. & Rock, C.O., The Structural Biology of Type II Fatty Acid Biosynthesis, Annu. Rev. Biochem., 74, 791-831, 2005.

a) Smith, S., Witkowski, A. & Joshi, A.K., Prog. Lipid Res., 42, 289-317, 2003. b) Asturias, F.J., Chadick, J.Z., Cheung, I.K., Stark, H., Witkowski, A., Joshi, A.K. & Smith, S., Structure and Molecular Organization of Mammalian Fatty Acid Synthase, Nat. Struct. Mol. Biol., 12, 225-232, 2005.

a) Campbell, J.W. & Cronan, J.E., Bacterial Fatty Acid Biosynthesis: Targets for Antibacterial Drug Discovery, Annu. Rev. Microbiol., 55, 305-332, 2001. b) Heath, R.J. & Rock, C.O., Fatty Acid Biosynthesis as A Target For Novel Antibacterials, Curr. Opin. Investig. Drugs, 5, 146-153, 2004. c) Zhang, Y.M., White, S.W. & Rock, C.O., Inhibiting Bacterial Fatty Acid Synthesis, J. Biol. Chem., 281, 17541-17544, 2006.

Cronan, J.E. & Waldrop, G.L., Multi-subunit Acetyl-CoA Carboxylases, Prog. Lipid Res., 41, 407-435, 2002.

a) Freiberg, C., Brunner, N.A., Schiffer, G., Lampe, T., Pohlmann, J., Brands, M., Raabe, M., Häbich, D. & Ziegelbauer, K., Identification and Characterization of The First Class of Potent Bacterial Acetyl-CoA Carboxylase Inhibitors With Antibacterial Activity, J. Biol. Chem. 279, 26066-26073, 2004. b) Lin, T.W., Melgar, M.M., Kurth, D., Swamidass, S.J., Purdon, J., Tseng, T., Gago, G., Baldi, P., Gramajo, H. & Tsai, S.C., Structure-Based Inhibitor Design of AccD5, an Essential Acyl-CoA Carboxylase Carboxyltransferase Domain Of Mycobacterium Tuberculosis, Proc. Natl. Acad. Sci. USA, 103, 3072-3077, 2006.

De Lay, N.R. & Cronan, J.E., In Vivo Functional Analyses of The Type II Acyl Carrier Proteins of Fatty Acid Biosynthesis, J. Biol. Chem., 282, 20319-20328, 2007.

Gajiwala, K.S., Margosiak, S., Lu, J., Cortez, J., Su, Y., Nie, Z. & Appelt, K., Crystal Structures of Bacterial FabH Suggest a Molecular Basis for The Substrate Specificity of The Enzyme, FEBS Lett., 583, 2939-2946, 2009.

Price, A.C., Zhang, Y.M., Rock, C.O. & White, S.W., Structure of Beta-Ketoacyl-[Acyl Carrier Protein] Reductase from Escherichia Coli: Negative Cooperativity and Its Structural Basis, Biochemistry, 40, 12772-12781, 2001.

a) Tasdemir, D., Lack, G., Brun, R., Ruedi, P., Scapozza, L. & Perozzo, R., Inhibition of Plasmodium falciparum Fatty Acid Biosynthesis: Evaluation of FabG, FabZ, and FabI as Drug Targets for Flavonoids, J. Med. Chem., 49, 3345-3353, 2006. b) Kristan, K., Bratkovic, T., Sova, M., Gobec, S., Prezelj, A. & Urleb, U., Novel Inhibitors of Beta-Ketoacyl-ACP Reductase from Escherichia Coli, Chem. Biol. Interact., 178, 310-316, 2009.

Marrakchi, H., Choi, K.H. & Rock, C.O., A New Mechanism for Anaerobic Unsaturated Fatty Acid Formation in Streptococcus Pneumoniae, J. Biol. Chem., 277, 44809-44816, 2002.

Wang, H.H. & Cronan, J.E., Functional Replacement of the FabA and FabB Proteins of Escherichia Coli Fatty Acid Synthesis by Enterococcus Faecalis FabZ and FabF Homologues, J. Biol. Chem., 279, 34489-34495, 2004.

He, L.Y., Zhang, L., Liu, X.F., Li, X.H., Zheng, M.Y., Li, H.L., Yu, K.Q., Chen, K.X., Shen, X., Jiang, H.L. & Liu, H., Discovering Potent Inhibitors Against The Beta-Hydroxyacyl-Acyl Carrier Protein Dehydratase (FabZ) of Helicobacter Pylori: Structure-Based Design, Synthesis, Bioassay, And Crystal Structure Determination, J. Med. Chem., 52, 2465-2481, 2009.

Lu, H. & Tonge, P.J., Inhibitors of FabI, An Enzyme Drug Target in the Bacterial Fatty Acid Biosynthesis Pathway, Acc. Chem. Res., 41, 11-20, 2008.

Heath, R.J. & Rock, C.O., A Triclosan-Resistant Bacterial Enzyme, Nature, 406, 145-146, 2000.

Marrakchi, H., Zhang, Y.M. & Rock, C.O., Mechanistic Diversity and Regulation of Type II fatty acid synthesis, Biochem. Soc. Trans., 30, 1050-1055, 2002.

Matsumae, A., Nomura, S. & Hata, T., Studies on Cerulenin. IV. Biological Characteristics of Cerulenin, J. Antibiot., 17, 1-7, 1964.

Noto, T., Miyakawa, S., Oishi, H., Endo, H. & Okazaki, H., Thiolactomycin, a New Antibiotic. III. In Vitro Antibacterial Activity, J. Antibiot., 35, 401-410, 1982.

For A Recent Review on The Total Synthesis of Platensimycin, Platencin and Related Analogues See: Palanichamy, K. & Kaliappan, K.P., Discovery and Syntheses of "Superbug Challengers"-Platensimycin and Platencin, Chem. Asian J., 5, 668-703, 2010.

a) Nicolaou, K.C., Lister, T., Denton, R.M., Montero, A. & Edmonds, D.J., Adamantaplatensimycin: A Bioactive Analogue of Platensimycin, Angew. Chem. Int. Ed., 46, 4712-4714, 2007. b) Nicolaou, K.C., Tang, Y., Wang, J., Stepan, A.F., Li, A. & Montero, A., Total Synthesis and Antibacterial Properties of Carbaplatensimycin, J. Am. Chem. Soc., 129, 14850-14851, 2007. c) Nicolaou, K.C., Stepan, A.F., Lister, T., Li, A., Montero, A., Tria, G.S., Turner, C.I., Tang, Y., Wang, J., Denton, R.M. & Edmonds, D.J., Design, Synthesis, and Biological Evaluation of Platensimycin Analogues with Varying Degrees of Molecular Complexity, J. Am. Chem. Soc., 130, 13110-13119, 2008. d) Yeung, Y.-Y. & Corey, E.J., A Simple, Efficient, and Enantiocontrolled Synthesis of A Near-Structural Mimic of Platensimycin, Org. Lett., 10, 3877-3878, 2008. e) Wang, J., Lee, V. & Sintim, H.O., Chem. Eur. J., 15, 2747-2750, 2009. f) Shen, H.C., Ding, F.-X., Singh, S.B., Parthasarathy, G., Soisson, S.M., Ha, S.N., Chen, X., Kodali, S., Wang, J., Dorso, K., Tata, J.R., Hammond, M.L., MacCoss, M. & Colletti, S.L., Synthesis and Biological Evaluation of Platensimycin Analogs, Bioorg. Med. Chem. Lett., 19, 1623-1627, 2009. g) Patra, M., Gasser, G., Pinto, A., Merz, K., Ott, I., Bandow, Julia E. & Metzler-Nolte, N., Synthesis and Biological Evaluation of Chromium Bioorganometallics Based on the Antibiotic Platensimycin Lead Structure, ChemMedChem., 4, 1930-1938, 2009. h) Jang, K.P., Kim, C.H., Na, S.W., Kim, H., Kang, H. & Lee, E., Isoplatensimycin: Synthesis and Biological Evaluation, Bioorg. Med. Chem. Lett., 19, 4601-4602, 2009.

Barykina, O.V., Rossi, K.L., Rybak, M.J. & Snider, B.B., Synthesis and Antibacterial. Properties of (–)-nor-Platencin, Org. Lett., 11, 5334-5337, 2009.

Tiefenbacher, K., Gollner, A. & Mulzer, J., Syntheses and Antibacterial Properties of iso-Platencin, Cl-iso-Platencin and Cl-Platencin: Identification of a New Lead Structure, Chem. Eur. J., 16, 9616–9622, 2010.

Waalboer, D.C.J., Schaapman, M.C., van Delft, F.L. & Rutjes, F.P.J.T., High-Pressure Entry Into Platencin, Angew. Chem Int. Ed., 47, 6576-6578, 2008.

Waalboer, D.C.J., Leenders, S.H.A.M., Schülin-Casonato, T., van Delft, F.L. & Rutjes, F.P.J.T., Total Synthesis and Antibiotic Activity of Dehydrohomoplatencin, Chem. Eur. J., 16, 11233-11236, 2010.

For a review of the Prins reaction, see: a) Arundale, E. & Mikeska, L.A., The Olefin-Aldehyde Condensation. The Prins Reaction, Chem. Rev., 51, 505-555, 1952. b) Adams, D.R. & Bhatnagar, S.P., The Prins Reaction, Synthesis, 661-672, 1977. c) Pastor, I.M. & Yus, M., The Prins Reaction: Advances and Applications, Curr. Org. Chem., 11, 925-957, 2007.

Nicolaou, K.C., Li, A. & Edmonds, D.J., Total Synthesis of Platensimycin, Angew. Chem. Int. Ed., 45, 7086-7090, 2006.

Nicolaou, K.C., Tria, G.S. & Edmonds, D.J., Total Synthesis of Platencin, Angew. Chem. Int. Ed., 47, 1780-1783, 2008.

Heretsch, P. & Giannis, A., Resorcylic Acid Derivatives for the Synthesis of Platensimycin and Analogues, Synthesis, 2614-2616, 2007.

Wang, J., Soisson, S.M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y.S., Cummings, R., Ha, S., Dorso, K., Motyl, M., Jayasuriya, H., Ondeyka, J., Herath, K., Zhang, C., Hernandez, L., Allocco, J., Basilio, Á., Tormo, J.R., Genilloud, O., Vicente, F., Pelaez, F., Colwell, L., Lee, S.H., Michael, B., Felcetto, T., Gill, C., Silver, L.L., Hermes, J.D., Bartizal, K., Barrett, J., Schmatz, D., Becker, J.W., Cully, D. & Singh, S.B., Platensimycin is a Selective FabF Inhibitor with Potent Antibiotic Properties, Nature, 441, 358-361, 2006.

Wang, J., Kodali, S., Lee, S.H., Galgoci, A., Painter, R., Dorso, K., Racine, F., Motyl, M., Hernandez, L., Hinney, E., Colletti, S.L., Herath, K., Cummings, R., Salazar, O., González, I., Basilio, A., Vicente, F., Genilloud, O., Pelaez, F., Jayasuriya, H., Young, K., Cully, D.F. & Singh, S.B., Discovery of Platencin, a Dual FabF and FabH Inhibitor with In Vivo Antibiotic Properties, Proc. Natl. Acad. Sci. USA, 104, 7612-7616, 2007.

See supporting information of: Wang, J., Soisson, S.M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y.S., Cummings, R., Ha, S., Dorso, K., Motyl, M., Jayasuriya, H., Ondeyka, J., Herath, K., Zhang, C., Hernandez, L., Allocco, J., Basilio, Á., Tormo, J.R., Genilloud, O., Vicente, F., Pelaez, F., Colwell, L., Lee, S.H., Michael, B., Felcetto, T., Gill, C., Silver, L.L., Hermes, J.D., Bartizal, K., Barrett, J., Schmatz, D., Becker, J.W., Cully, D. & Singh, S.B., Platensimycin is a Selective FabF Inhibitor With Potent Antibiotic Properties, Nature, 441, 358-361, 2006.

For the Crystal Structure of E.coli FabF(C163A) in Complex with Platencin, see PDB file 3HO2.




DOI: http://dx.doi.org/10.5614%2Fitbj.sci.2011.43.2.3

Refbacks

  • There are currently no refbacks.


View my Stats

Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

 

ITB Journal Publisher, LPPM ITB, Center for Research and Community Services (CRCS) Building, 6th & 7th Floor, Jalan Ganesha 10, Bandung 40132, Indonesia, Phone: +62-22-86010080, Fax.: +62-22-86010051; E-mail: jmfs@lppm.itb.ac.id